Table 1.
Characteristics of patients
| Surgery + HFSRT N = 99 |
HFSRT N = 328 |
pValue | |
|---|---|---|---|
| Age | 0.1511 | ||
| Median [min - max] | 59.0 [13.2–87.0] | 60.8 [8.3–85.9] | |
| Sex | 0.4587 | ||
| male | 52 (52.5%) | 185 (56.7%) | |
| Female | 47 (47.5%) | 143 (43.3%) | |
| KPS | 0.25 | ||
| 100–90 | 38 (38%) | 96 (30%) | |
| 80–70 | 46 (46%) | 169 (52%) | |
| < 70 | 15 (15%) | 60 (18%) | |
| RPA | <.0001 | ||
| 1 | 29 (29.3%) | 35 (10.7%) | |
| 2 | 55 (55.6%) | 233 (71.0%) | |
| 3 | 15 (15.2%) | 60 (18.3%) | |
| m RPA | < 0.001 | ||
| 1 + 2a | 55 (56%) | 89 (27%) | |
| 2b | 17 (17%) | 90 (28%) | |
| 2c + 3 | 27 (27%) | 146 (45%) | |
| GPA | 0.0868 | ||
| < = 3 | 98 (99.0%) | 311 (94.8%) | |
| > 3 | 1 (1.0%) | 17 (5.2%) | |
| DS-GPA | 0.2485 | ||
| < = 3 | 78 (87.6%) | 265 (91.7%) | |
| > 3 | 11 (12.4%) | 24 (8.3%) | |
| Not applicable | 10 | 39 | |
| Survival at the last follow-up | 0.0227 | ||
| Alive | 63 (63.6%) | 166 (50.6%) | |
| Dead | 36 (36.4%) | 162 (49.4%) | |
| Extracranial control | 0.0001 | ||
| Yes | 49 (49.5%) | 116 (34.4%) | |
| No | 41 (41.4%) | 182 (55.5%) | |
| NC | 9 (9.1%) | 30 (9.1%) | |
| Neurologic symptoms | <.0001 | ||
| No | 77 (77.8%) | 133 (52.0%) | |
| Yes | 22 (22.2%) | 123 (48.0%) | |
| NC | 0 | 72 | |
| Systemic treatement | 0.3197 | ||
| No | 56 (58.3%) | 197 (64.0%) | |
| Yes | 40 (41.7%) | 111 (36.0%) | |
| Control of primary tumor | 0.6333 | ||
| Yes | 49 (50.5%) | 148 (47.7%) | |
| No | 50 (49.5%) | 180 (52.3%) |